2nd Quarter - Report

BROWN RUDNICK LLP for PRIME THERAPEUTICS

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

P.L 111-148 - The Affordable Care Act implementation relating to pharmacy claims of QHP enrollees.

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow(05-07)
HENRY W MENN Min SD & Counsel, Cmte on Vet Affairs (04)

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

-S.867 Medicare Prescription Drug Program Integrity and Transparency Act of 2013 -Issues relating to price negotiation and preferred pharmacy networks in the Medicare Part D program.

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow(05-07)
HENRY W MENN Min SD & Counsel, Cmte on Vet Affairs (04)

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 867 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.